Osmosis Investment Management UK Ltd Purchases Shares of 2,777 Equifax, Inc. $EFX

Osmosis Investment Management UK Ltd purchased a new position in Equifax, Inc. (NYSE:EFX) in the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm purchased 2,777 shares of the credit services provider’s stock, valued at approximately $441,000.

A number of other large investors have also modified their holdings of the business. Brighton Jones LLC boosted its stake in Equifax by 49.2% in the 4th quarter. Brighton Jones LLC now owns 3,638 shares of the credit services provider’s stock worth $927,000 after purchasing an additional 1,200 shares in the last quarter. Great Lakes Advisors LLC acquired a new position in Equifax during the 1st quarter valued at approximately $204,000. Empowered Funds LLC raised its holdings in shares of Equifax by 14.6% in the first quarter. Empowered Funds LLC now owns 2,523 shares of the credit services provider’s stock worth $615,000 after buying an additional 321 shares during the last quarter. First Trust Advisors LP raised its holdings in shares of Equifax by 14.5% in the second quarter. First Trust Advisors LP now owns 7,632 shares of the credit services provider’s stock worth $1,979,000 after buying an additional 966 shares during the last quarter. Finally, AXA S.A. lifted its stake in shares of Equifax by 699.9% during the second quarter. AXA S.A. now owns 8,671 shares of the credit services provider’s stock worth $2,249,000 after buying an additional 7,587 shares during the period. Hedge funds and other institutional investors own 96.20% of the company’s stock.

Equifax Price Performance

Shares of EFX opened at $192.16 on Wednesday. The business’s 50-day moving average is $173.25 and its two-hundred day moving average is $178.19. The company has a market capitalization of $22.58 billion, a P/E ratio of 33.77, a P/E/G ratio of 1.56 and a beta of 1.30. Equifax, Inc. has a fifty-two week low of $150.74 and a fifty-two week high of $271.84. The company has a debt-to-equity ratio of 0.92, a quick ratio of 0.60 and a current ratio of 0.60.

Equifax (NYSE:EFX) last issued its quarterly earnings data on Tuesday, July 21st. The credit services provider reported $2.25 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.20 by $0.05. Equifax had a return on equity of 21.61% and a net margin of 10.73%.The business had revenue of $1.70 billion during the quarter, compared to analysts’ expectations of $1.70 billion. During the same quarter in the previous year, the firm posted $2.00 EPS. The company’s revenue for the quarter was up 10.6% on a year-over-year basis. Equifax has set its Q3 2026 guidance at 2.150-2.250 EPS and its FY 2026 guidance at 8.390-8.690 EPS. Research analysts predict that Equifax, Inc. will post 8.58 earnings per share for the current year.

Equifax Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Tuesday, September 15th. Investors of record on Monday, August 31st will be issued a dividend of $0.56 per share. The ex-dividend date of this dividend is Monday, August 31st. This represents a $2.24 dividend on an annualized basis and a yield of 1.2%. Equifax’s dividend payout ratio is 39.37%.

Insider Transactions at Equifax

In related news, CEO Mark W. Begor sold 37,791 shares of the firm’s stock in a transaction on Friday, July 24th. The shares were sold at an average price of $172.16, for a total transaction of $6,506,098.56. Following the sale, the chief executive officer owned 271,890 shares in the company, valued at approximately $46,808,582.40. This trade represents a 12.20% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Company insiders own 1.70% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of brokerages have recently weighed in on EFX. The Goldman Sachs Group reissued a “neutral” rating and set a $182.00 price objective on shares of Equifax in a report on Tuesday, July 21st. Wells Fargo & Company lowered their price target on Equifax from $220.00 to $212.00 and set an “overweight” rating for the company in a research report on Wednesday, July 22nd. Rothschild & Co Redburn upgraded Equifax from a “neutral” rating to a “buy” rating and boosted their price target for the company from $214.00 to $235.00 in a research note on Friday. Robert W. Baird cut their price objective on Equifax from $245.00 to $232.00 and set an “outperform” rating on the stock in a report on Wednesday, July 22nd. Finally, Morgan Stanley reduced their price objective on Equifax from $243.00 to $225.00 and set an “overweight” rating for the company in a research note on Wednesday, July 22nd. Fourteen research analysts have rated the stock with a Buy rating and six have given a Hold rating to the company’s stock. Based on data from MarketBeat, the company has an average rating of “Moderate Buy” and a consensus price target of $216.89.

Equifax Company Profile

Equifax Inc (NYSE: EFX) is a global data, analytics and technology company that specializes in consumer and commercial credit reporting, decisioning tools and identity solutions. Headquartered in Atlanta, Georgia, Equifax is one of the three major consumer credit reporting agencies in the United States and provides credit information and related services to lenders, employers, governments and consumers worldwide.

The company’s offerings include consumer credit reports and scores, credit monitoring and identity protection services, and a range of business-oriented products for risk management, fraud detection and compliance.